Exploring the interactions of rapamycin with target receptors in A549 cancer cells: insights from molecular docking analysis
Abstract Rapamycin, a macrocyclic antibiotic derived from the actinomycetes Streptomyces hygroscopicus, is a widely used immunosuppressant and anticancer drug. Even though rapamycin is regarded as a multipotent drug acting against a broad array of anomalies and diseases, the mechanism of action of r...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer
2025-01-01
|
| סדרה: | Journal of Cancer Research and Clinical Oncology |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1007/s00432-024-06072-y |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|